Russell Investments Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Russell Investments Group’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.59K	Buy	+25	New	+$2.64K	﹤0.01%	3977

Other funds holding PJP

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Russell Investments Group's PJP Position: Q1 2026 in Review

Russell Investments Group opened a new position in Invesco Pharmaceuticals ETF (PJP) in Q1 2026: 25 shares worth $2.59K. The stake represents ﹤0.01% of the portfolio and ranks #3977 among its holdings.

119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

Russell Investments Group held 25 shares of Invesco Pharmaceuticals ETF worth $2.59K as of Q1 2026.
Invesco Pharmaceuticals ETF was a new Russell Investments Group position in Q1 2026.
Invesco Pharmaceuticals ETF made up ﹤0.01% of Russell Investments Group's portfolio in Q1 2026, its #3977 holding.
119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Russell Investments Group's 13F filing for Q1 2026, filed 8 May 2026.